Michael D. Mallory
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael D. Mallory has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Amy Lynn Baxter
Department of Emergency Medicine, Augusta University, Augusta, GA, United States
2 shared publications - Courtney McCracken
Department of Pediatrics, Emory University School of Medicine, 2015 Uppergate Drive, Atlanta, GA, 30322, USA.
2 shared publications - Pradip P. Kamat
Emory University School of Medicine, Children’s Healthcare of Atlanta
2 shared publications Daniel A. Hirsh
Pediatric Emergency Medicine Associates, Children's Healthcare of Atlanta at Scottish Rite, Atlanta, GA, USA
1 shared publicationDaniel J. Yanosky
1 shared publicationElan Jenkins
Department of Pediatrics, Emory University School of Medicine, 1405 Clifton Road NE, Atlanta, GA, 30322, USA
1 shared publication
Latest Publications
- 1 June 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 44, 198-202
Sedatives used in children to obtain head CT in the emergency department
- 1 June 2021
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 44, 198-202
Sedatives used in children to obtain head CT in the emergency department
- 9 May 2017
- Published by Springer Nature in Pediatric Radiology
- Vol. 47 (8) , 974-983
Experience with the use of propofol for radiologic imaging in infants younger than 6 months of age
- 9 May 2017
- Published by Springer Nature in Pediatric Radiology
- Vol. 47 (8) , 974-983
Experience with the use of propofol for radiologic imaging in infants younger than 6 months of age
- 1 May 2011
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 57 (5) , 462-468.e1
Emergency Physician–Administered Propofol Sedation: A Report on 25,433 Sedations From the Pediatric Sedation Research Consortium
- 1 May 2011
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 57 (5) , 462-468.e1
Emergency Physician–Administered Propofol Sedation: A Report on 25,433 Sedations From the Pediatric Sedation Research Consortium
- 6 May 2009
- Published by Wiley in Pediatric Anesthesia
- Vol. 19 (6) , 601-611
Propofol vs pentobarbital for sedation of children undergoing magnetic resonance imaging: results from the Pediatric Sedation Research Consortium
Summary: Background: Pentobarbital and propofol are commonly used to sedate children undergoing magnetic resonance imaging (MRI). The Pediatric Sedation Research Consortium (PSRC) was created in 2003 to improve pediatric sedation process and outcomes.Objective: To use PSRC records to compare the effectiveness, efficiency and adverse events of propofol vs pentobarbital for sedation of children undergoing MRI.Methods: Pediatric Sedation Research Consortium records of children aged 6 months to 6 years who were primarily sedated with either i.v. pentobarbital or propofol were included. Participating PSRC investigators obtained institutional review board approval before data collection.Results: Of 11 846 sedations for MRI, 7079 met inclusion criteria (propofol: n = 5072; pentobarbital: n = 2007). Demographic details were similar between the two groups. Ideal sedation was produced in 96.45% of the pentobarbital group and in 96.8% of the propofol group (P = 0.478), but pentobarbital was more likely to result in poor sedation canceling the procedure (OR 5.88; CI 2.24, 15.40). Propofol resulted in physiologic changes more frequently than did pentobarbital (OR 5.69; CI 1.35, 23.97). Pentobarbital was associated with prolonged recovery (OR 16.82; CI 4.98, 56.8), unplanned admission (OR 5.60; CI 1.02, 30.82), vomiting (OR 36.76; CI 4.84, 279.2) and allergic complication (OR 9.15; CI 1.02, 82.34). The incidence of airway complications was not significantly different between the two. The median recovery time for patients receiving propofol was 30 min, whereas for pentobarbital it was 75 min (P < 0.001).Conclusion: Among institutions contributing data to the PSRC, it is found that propofol provides more efficient and effective sedation than pentobarbital for children undergoing MRI. Although apnea occurred with a greater frequency in patients who received propofol, the rate of apnea and airway complications for propofol was not statistically different from that seen in patients who received pentobarbital.
- 6 May 2009
- Published by Wiley in Pediatric Anesthesia
- Vol. 19 (6) , 601-611
Propofol vs pentobarbital for sedation of children undergoing magnetic resonance imaging: results from the Pediatric Sedation Research Consortium
Summary: Background: Pentobarbital and propofol are commonly used to sedate children undergoing magnetic resonance imaging (MRI). The Pediatric Sedation Research Consortium (PSRC) was created in 2003 to improve pediatric sedation process and outcomes.Objective: To use PSRC records to compare the effectiveness, efficiency and adverse events of propofol vs pentobarbital for sedation of children undergoing MRI.Methods: Pediatric Sedation Research Consortium records of children aged 6 months to 6 years who were primarily sedated with either i.v. pentobarbital or propofol were included. Participating PSRC investigators obtained institutional review board approval before data collection.Results: Of 11 846 sedations for MRI, 7079 met inclusion criteria (propofol: n = 5072; pentobarbital: n = 2007). Demographic details were similar between the two groups. Ideal sedation was produced in 96.45% of the pentobarbital group and in 96.8% of the propofol group (P = 0.478), but pentobarbital was more likely to result in poor sedation canceling the procedure (OR 5.88; CI 2.24, 15.40). Propofol resulted in physiologic changes more frequently than did pentobarbital (OR 5.69; CI 1.35, 23.97). Pentobarbital was associated with prolonged recovery (OR 16.82; CI 4.98, 56.8), unplanned admission (OR 5.60; CI 1.02, 30.82), vomiting (OR 36.76; CI 4.84, 279.2) and allergic complication (OR 9.15; CI 1.02, 82.34). The incidence of airway complications was not significantly different between the two. The median recovery time for patients receiving propofol was 30 min, whereas for pentobarbital it was 75 min (P < 0.001).Conclusion: Among institutions contributing data to the PSRC, it is found that propofol provides more efficient and effective sedation than pentobarbital for children undergoing MRI. Although apnea occurred with a greater frequency in patients who received propofol, the rate of apnea and airway complications for propofol was not statistically different from that seen in patients who received pentobarbital.